Inhibition of IRE1?-driven pro-survival pathways is a promising therapeutic application in acute myeloid leukemia

by Sun, H, Lin, D.-C, Guo, X, Masouleh, B.K, Gery, S, Cao, Q, Alkan, S, Ikezoe, T, Akiba, C, Paquette, R, Chien, W, Müller-Tidow, C, Jing, Y, Agelopoulos, K, Müschen, M, Koeffler, H.P
Published 2020